Analysts have provided the following ratings for Phreesia (NYSE:PHR) within the last quarter:
The size of the global Clinical Documentation Software market was estimated to be USD 655.92 in 2021 and to increase to USD 1466.09 by 2028, with a
The size of the global Clinical Documentation Software market was estimated to be USD 655.92 in 2021 and to increase to USD 1466.09 by 2028, with a
Welcome to the Denver Gazette’s Metro Moves. You’ll get the latest metro Denver openings, closings, hiring and promotion briefs here. To submit your company’s news, drop an email to dennis.huspeni@gazette.com.
Advertising for constipation treatments often uses light-hearted humor in an effort to spur open discussions about the sometimes stigmatized topic. However, that may not be enough to get people to take the condition seriously, a new patient report from Phreesia finds. Fewer than one-fifth (17%) of p…
New report on Clinical Documentation Software Market which incorporated the analysis of different factors that augment the market’s growth to the end of
Patient Intake Software Market Report Coverage: Key Growth Factors & Challenges, Segmentation
The speed of change in the healthcare world is nothing short of astounding. Individuals are now able to track their
Phreesia, Inc. (NYSE:PHR - Get Rating) SVP Michael J. Davidoff sold 1,296 shares of the business’s stock in a transaction dated Friday, September 16th. The stock was sold at an average price of $27.60, for a total transaction of $35,769.60. Following the transaction, the senior vice president now ow…
The global Clinical Documentation Software market size was valued at USD 655.92 million in 2021 and is expected to expand at a CAGR of 14.35% during the
Phreesia, Inc. (NYSE:PHR - Get Rating) has received an average rating of “Moderate Buy” from the fourteen ratings firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to
Clinical Documentation Software Market Report covers several important factors like key market trends, growth forecast, and growth opportunities, market
Phreesia is proud to announce that Zeeshan Butt, PhD, a Director of Clinical Content, has been selected to serve a three-year term as a member of the
KeyCorp assumed coverage on shares of Phreesia in a report on Thursday. They issued an “overweight” rating on the stock.
The report on Global 2022-2029 Global Patient Experience Software Professional Market Research Report, Analysis from Perspective of Segmentation
Phreesia, Inc. (NYSE:PHR - Get Rating) - Analysts at SVB Leerink upped their Q3 2023 EPS estimates for Phreesia in a research report issued on Wednesday, September 7th. SVB Leerink analyst S. Davis now forecasts that the company will earn ($0.86) per share for the quarter, up from their previous
Patient Experience Software Market Global 2022 presents detailed competitive analysis including the market Share, Size, Future scope. This study
Phreesia shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 67 to 81.
The healthcare industry is growing faster than any other sector, and the demand for digital solutions in the medical field